Surveillance, Diagnosis and Management of Clostridium difficile Infection in Ireland Update of 2008 Guidance
Guidelines for Control and Prevention of Multi-Drug Resistant Organisms (MDRO) Excluding MRSA in the Healthcare Setting
In April 2013, a small amendment was made to the initial version of this guideline, which was initially published in February 2013. The guideline has been amended to provide clarification and to ensure consistency with recommendations of other national guidelines. The majority of waste from a room occupied by a patient/resident with a multi-drug resistant organism, as described in this guideline, should be considered to be non-risk waste, e.g., gloves and aprons, unless contaminated with blood or potentially infectious body substances.
These guidelines were developed by the Steering group of the second national prevalence study in long term care and the SARI community antimicrobial stewardship committee. Further information on the second national prevalence study can be found here. With the advent of the RCPI /HSE clinical programme on healthcare-associated infection and antimicrobial resistance, the SARI committee(s) agreed to complete its work and hand over its functions to a new committee. A new national committee was established in September 2011 under RCPI governance; the RCPI Clinical Advisory Group on Healthcare-associated Infection. This committee has taken over the functions of the SARI National Committee - Dr. Nuala O’ Connor represents the ICGP on this national committee.
The 2005 MRSA guidelines have recently been updated after a consultation period. The revised guidelines were approved by the clinical advisory group of the National Clinical Programme for the prevention of HCAI & AMR, reviewed by the National Clinical Effectiveness Committee (NCEC) and subsequently revised. This revised version has been resubmitted for approval to the NCEC in April 2013.
Guidelines for Antimicrobial Prescribing in Primary Care in Ireland - online version February 2013.
SARI Prevention of Intravascular Catheter-related Infection Sub-Committee
SARI Hospital Antimicrobial Stewardship Working Group.
The following guidelines are also relevant to infection control teams:
National Guidelines for the Prevention of Nosocomial Invasive Aspergillosis during Construction/Renovation Activities (2002)
In Europe from February 1st 2013, it will be illegal to sell or use water treatment systems that use elemental copper in order to add copper ions to water as a biocide. It will also be illegal to supply the copper needed for their use. The action has been taken at EU Level under the Biocidal Product Regulation (BPR, Regulation (EU) 528/2012) because no manufacturer supported the use of elemental copper for use as biocides in these systems during a review period that ended in September 2011.
See also UK HSE's information 29/11/2012, amended 30/01/2013 here
Latest update (July 2013) on important information for users and suppliers of water treatment systems that use elemental copper for legionella control. See http://www.hse.gov.uk/legionnaires/faqs.htm#silver-copper-systems
Date added: 29 August 2013
Guidelines on Minimising the Risk of Transmission of Transmissible Spongiform Encephalopathies in Healthcare Settings in Ireland (2004)
National Guidelines On The Management Of Outbreaks Of Norovirus Infection In Healthcare Settings (2003)